Bérard, Emilie
Röllig, Christoph
Bertoli, Sarah http://orcid.org/0000-0003-1084-2781
Pigneux, Arnaud
Tavitian, Suzanne
Kramer, Michael
Serve, Hubert
Bornhäuser, Martin
Platzbecker, Uwe
Müller-Tidow, Carsten
Baldus, Claudia D. http://orcid.org/0000-0002-0748-834X
Martínez-Cuadrón, David http://orcid.org/0000-0001-7540-4091
Serrano, Josefina
Martínez-Sánchez, Pilar
Arbolí, Eduardo Rodríguez http://orcid.org/0000-0002-2237-6733
Gil, Cristina
Bergua, Juan
Bernal, Teresa
de la Fuente Burguera, Adolfo
Delabesse, Eric http://orcid.org/0000-0002-0928-0753
Bidet, Audrey http://orcid.org/0000-0003-0992-8377
Dumas, Pierre-Yves
Montesinos, Pau http://orcid.org/0000-0002-3275-5593
Récher, Christian http://orcid.org/0000-0002-3332-4525
Funding for this research was provided by:
Fondation Toulouse Cancer Santé
Article History
Received: 7 April 2022
Revised: 20 June 2022
Accepted: 22 June 2022
First Online: 11 July 2022
Competing interests
: Christian Récher: Research grants from AbbVie, Amgen, Novartis, BMS-Celgene, Jazz Pharmaceuticals, Agios, Chugai, MaaT Pharma, Astellas, Roche, Daiichi-Sankyo, and Iqvia; advisor for AbbVie, Janssen, Jazz Pharmaceuticals, Novartis, Celgene, Otsuka, Astellas, Daiichi-Sankyo, Macrogenics, Pfizer, Roche, Servier, and Takeda. Christoph Röllig: Research grants from AbbVie, Bayer, Celgene, Janssen, Novartis, Pfizer; advisor for AbbVie, Amgen, BMS/Celgene, Daiichy Sankyo, Janssen, Jazz, Novartis, Pfizer, Roche and Takeda. Pau Montesinos: Research grants from AbbVie, Novartis, BMS-Celgene, Jazz Pharmaceuticals, Astellas, and Daiichi-Sankyo; advisor for AbbVie, Janssen, Jazz Pharmaceuticals, Novartis, Celgene, Astellas, Daiichi-Sankyo, Roche, Takeda, and Pfizer. Arnaud Pigneux: Grant/Research Support: Astellas, Roche; Speaker’s Bureau: Astellas, AbbVie, Gilead, Pfizer, Roche, Sanofi; Consultant: Jazz, AbbVie, Agios, BMS, Gilead, Novartis, Pfizer, Roche, and Takeda. Michael Kramer: consultant for GEMoaB and Cellex Patient Treatment. Audrey Bidet: advisory boards for Daiichi-Sankyo and Novartis. Pierre-Yves Dumas: Daiichi-Sankyo, Jazz Pharmaceutical, Astellas, AbbVie, Celgene, Janssen. Sarah Bertoli: advisor for Abbvie, Jazz Pharmaceuticals, Daiichi-Sankyo, Sanofi, Astellas, and BMS. Emilie Bérard: no competing interest.